We recently compiled a list of the 10 Best Healthcare Stocks to Buy and Hold for 3 Years. Gilead Sciences, Inc. is one of the best healthcare stocks.
TheFly reported on April 10 that Morgan Stanley increased its price target for GILD to $175 from $171 while maintaining an Overweight rating. The adjustment reflects updated financial models across the firm’s biopharmaceutical coverage universe. The revision incorporates recent industry data trends from IQVIA as well as intra-quarter performance updates ahead of first-quarter earnings across the sector.
More recently, on April 14, Gilead Sciences, Inc. (NASDAQ:GILD) announced expanded global support for its long-acting HIV prevention therapy lenacapavir through collaboration with the U.S. State Department, the President’s Emergency Plan for AIDS Relief, and The Global Fund. The initiative increases planned access to the injectable treatment for up to 1 million additional individuals, raising the total commitment to approximately 3 million people in high-incidence, resource-limited regions through 2028. The program combines funding and distribution capabilities from international public health partners to improve delivery in areas with the greatest need.
These organizations will leverage established healthcare infrastructure to accelerate access and expand reach across multiple countries. Lenacapavir, administered twice yearly, has already begun reaching communities in sub-Saharan Africa shortly after regulatory approval in the United States, with initial shipments beginning in late 2025. The effort is part of a broader strategy to scale HIV prevention globally through coordinated partnerships and improved treatment accessibility.
Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical company focused on developing and commercializing antiviral drugs, including treatments for HIV, hepatitis B and C, and COVID-19. It also has expanding programs in oncology and inflammation, leveraging research in virology and immunology.
While we acknowledge the risk and potential of GILD as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than GILD and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 10 Best Healthcare Stocks to Buy and Hold for 3 Years and 10 Best Beaten Down Stocks to Invest in According to Analysts.
Disclosure: None. Follow Insider Monkey on Google News.
